Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-18 Purchase | 2022-11-22 08:00 am | Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director | 10,000 | $1.8945 | $18,945 | 75,374 (Direct) | View |
| 2022-09-08 Purchase | 2022-09-12 09:00 am | Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director | 10,308 | $2.8 | $28,862 | 65,374 (Direct) | View |
| 2022-09-06 Purchase | 2022-09-08 09:00 am | Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director | 9,692 | $2.5558 | $24,771 | 55,066 (Direct) | View |
| 2022-06-06 Purchase | 2022-06-07 08:00 am | Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director | 19,727 | $2.63 | $51,882 | 45,374 (Direct) | View |
| 2021-11-18 Purchase | 2021-11-19 09:16 am | Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director | 11,187 | $5.82 | $65,108 | 25,647 (Direct) | View |
| 2021-09-14 Purchase | 2021-09-16 6:22 pm | Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director | 12,000 | $7 | $84,000 | 14,460 (Direct) | View |
| 2019-08-28 Purchase | 2019-08-29 4:16 pm | Intec Pharma Ltd. | NTEC | Meckler Jeffrey A Chief Executive Officer | 20,000 | $0.681 | $13,620 | 196,761 (Direct) | View |
| 2019-08-23 Purchase | 2019-08-27 4:18 pm | Intec Pharma Ltd. | NTEC | Meckler Jeffrey A Chief Executive Officer | 100,000 | $0.457 | $45,700 | 176,761 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-22 Option Award | 2024-01-23 4:15 pm | N/A 2034-01-22 | Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-19 4:05 pm | 2024-05-17 2033-05-16 | Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director | 18,000 | $0 | 88,000 (Direct) | View |
| 2023-01-18 Option Award | 2023-01-20 4:05 pm | N/A 2033-01-18 | Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-05-11 Option Award | 2022-05-12 8:26 pm | 2023-05-11 2032-05-10 | Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director | 12,000 | $0 | 79,000 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 4:30 pm | N/A 2032-01-26 | Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director | 200,000 | $0 | 200,000 (Direct) | View |
| 2021-08-04 Option Award | 2021-08-06 5:00 pm | N/A 2031-08-04 | Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director | 375,000 | $0 | 375,000 (Direct) | View |
Ownership | 2021-08-02 4:45 pm | N/A N/A | Intec Parent Inc. | NTEC | Meckler Jeffrey A Chief Executive Officer | 0 | $0 | 16,086 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 9:19 pm | 2022-05-14 2031-05-13 | Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director | 12,000 | $0 | 76,000 (Direct) | View |
| 2020-07-15 Option Award | 2020-07-17 4:38 pm | N/A 2027-07-15 | Intec Pharma Ltd. | NTEC | Meckler Jeffrey A Chief Executive Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 8:00 pm | 2021-05-15 2030-05-14 | Retrophin Inc. | RTRX | Meckler Jeffrey A Director | 12,000 | $0 | 73,000 (Direct) | View |
| 2019-05-08 Option Award | 2019-05-10 8:37 pm | 2020-05-08 2029-05-07 | Retrophin Inc. | RTRX | Meckler Jeffrey A Director | 10,000 | $0 | 69,000 (Direct) | View |